CN Patent
CN101343296B — 钠-葡萄糖协同转运蛋白2的抑制剂及其用法
Assigned to Lexicon Pharmaceuticals Inc · Expires 2013-04-10 · 13y expired
What this patent protects
本发明公开了化合物和包括所述化合物的药物组合物,其可用于治疗疾病和病症例如糖尿病和肥胖症。
USPTO Abstract
本发明公开了化合物和包括所述化合物的药物组合物,其可用于治疗疾病和病症例如糖尿病和肥胖症。
Drugs covered by this patent
- Inpefa (SOTAGLIFLOZIN) · Lexicon Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.